The Predictive Value of Tumor Mutation Burden on Efficacy of Immune Checkpoint Inhibitors in Cancers: A Systematic Review and Meta-Analysis

Background: Despite an increasing understanding about tumor mutation burden (TMB) in cancer immunity and cancer immunotherapy, the comprehensive cognition between TMB and efficiency of immune checkpoint inhibitors (ICIs) is still lacking. A systematic review and meta-analysis was conducted to evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yongfeng, Xu, Jinming, Du, Chengli, Wu, Yihua, Xia, Dajing, Lv, Wang, Hu, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848266/
https://www.ncbi.nlm.nih.gov/pubmed/31750249
http://dx.doi.org/10.3389/fonc.2019.01161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848266/
https://www.ncbi.nlm.nih.gov/pubmed/31750249
http://dx.doi.org/10.3389/fonc.2019.01161

Ejemplares similares